Chugai Pharmaceutical Co., Ltd. (CHGCF)
41.61
-0.96
(-2.26%)
USD |
OTCM |
Sep 18, 16:00
Chugai Pharmaceutical Price to Book Value : 5.488 for Sept. 18, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 5.488 |
| September 17, 2026 | 5.614 |
| September 16, 2026 | 4.651 |
| September 15, 2026 | 5.431 |
| September 14, 2026 | 5.702 |
| September 11, 2026 | 5.638 |
| September 10, 2026 | 5.256 |
| September 09, 2026 | 5.456 |
| September 08, 2026 | 5.767 |
| September 04, 2026 | 5.716 |
| September 03, 2026 | 5.803 |
| September 02, 2026 | 5.486 |
| September 01, 2026 | 5.460 |
| August 31, 2026 | 5.837 |
| August 28, 2026 | 5.856 |
| August 27, 2026 | 5.774 |
| August 26, 2026 | 5.655 |
| August 25, 2026 | 5.593 |
| August 24, 2026 | 5.920 |
| August 21, 2026 | 5.543 |
| August 20, 2026 | 5.682 |
| August 19, 2026 | 5.648 |
| August 18, 2026 | 5.501 |
| August 17, 2026 | 5.907 |
| August 14, 2026 | 5.699 |
| Date | Value |
|---|---|
| August 13, 2026 | 5.748 |
| August 12, 2026 | 5.796 |
| August 11, 2026 | 5.677 |
| August 10, 2026 | 5.869 |
| August 07, 2026 | 5.656 |
| August 06, 2026 | 5.729 |
| August 05, 2026 | 5.455 |
| August 04, 2026 | 5.760 |
| August 03, 2026 | 5.577 |
| July 31, 2026 | 5.694 |
| July 30, 2026 | 6.142 |
| July 29, 2026 | 5.537 |
| July 28, 2026 | 5.516 |
| July 27, 2026 | 5.727 |
| July 24, 2026 | 6.377 |
| July 23, 2026 | 5.497 |
| July 22, 2026 | 5.756 |
| July 21, 2026 | 5.799 |
| July 20, 2026 | 5.883 |
| July 17, 2026 | 6.125 |
| July 16, 2026 | 5.844 |
| July 15, 2026 | 5.517 |
| July 14, 2026 | 5.653 |
| July 13, 2026 | 5.820 |
| July 10, 2026 | 5.870 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 1.285 |
| Daiichi Sankyo Co., Ltd. | 3.284 |
| Eisai Co., Ltd. | 1.59 |
| Santen Pharmaceutical Co., Ltd. | 1.928 |
| Ono Pharmaceutical Co., Ltd. | 1.343 |
Price to Book Value Related Metrics
| PE Ratio | 22.43 |
| PS Ratio | 7.87 |
| PEG Ratio | 1.451 |
| Price to Free Cash Flow | 29.26 |
| Price | 41.61 |
| Earnings Yield | 4.46% |
| Market Cap | 68.47B |
| PEGY Ratio | 1.200 |
| Operating PE Ratio | 15.60 |
| Normalized PE Ratio | 21.41 |